Ex Parte Maeda et alDownload PDFPatent Trial and Appeal BoardFeb 22, 201712596724 (P.T.A.B. Feb. 22, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 12/596,724 10/20/2009 Takeshi Maeda 14434.0272USWO 3978 52835 7590 02/24/2017 HAMRE, SCHUMANN, MUELLER & LARSON, P.C. 45 South Seventh Street Suite 2700 MINNEAPOLIS, MN 55402-1683 EXAMINER GREENE, IVAN A ART UNIT PAPER NUMBER 1619 NOTIFICATION DATE DELIVERY MODE 02/24/2017 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): PTOMail @hsml. com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte TAKESHI MAEDA, TOMOHIRO YAGYU, and KAZUHIRO OTANI1 Appeal 2016-001650 Application 12/596,724 Technology Center 1600 Before TAWEN CHANG, RYAN H. FLAX and DEVON ZASTROW NEWMAN, Administrative Patent Judges. FLAX, Administrative Patent Judge. DECISION ON APPEAL This is a decision on appeal under 35 U.S.C. § 134(a) involving claims directed to glass flakes. Claims 1—7 are on appeal as rejected under 35 U.S.C. § 103(a). We have jurisdiction under 35 U.S.C. § 6(b). We affirm. 1 We understand the Real Party in Interest to be NIPPON SHEET GLASS COMPANY, LIMITED. Br. 1. Appeal 2016-001650 Application 12/596,724 STATEMENT OF THE CASE The appealed claims can be found in the Claims Appendix of the Appeal Brief. Claims 1 and 7 are the independent claims; claim 1 is representative and reads as follows: 1. Glass flakes each comprising: a glass flake substrate; and a coating layer directly coating the surface of the glass flake substrate, wherein: the glass flake substrate has an average thickness of 0.1 to 1.0 pm, and an average particle size of 1 to 100 pm; the coating layer directly coated on the surface of the glass flake substrate consists of methyl hydrogen silicone as a sole coating agent applied to the glass flake substrate; and a content percentage of the methyl hydrogen silicone is 0.05 to 2.50 mass% relative to the glass flakes as determined by ignition loss at 625 ± 20°C. Br. 12 (Claims App’x). The following rejections are on appeal: Claims 1—7 stand rejected under 35 U.S.C. § 103(a) over Fujiwara,2 Imai,3 Schlossman,4 Miyazaki,5 and Shin-Etsu.6 Final Action 3. 2 U.S. Patent Application Pub. No. U.S. 2005/0049133 A1 (published Mar. 3, 2005) (hereinafter “Fujiwara”). 3 U.S. Patent Application Pub. No. U.S. 2005/0238596 A1 (published Oct. 27, 2005) (hereinafter “Imai”). 4 U.S. Patent Application Pub. No. U.S. 2004/0234613 A1 (published Nov. 25, 2004) (hereinafter “Schlossman”). 5 U.S. Patent Application Pub. No. U.S. 2005/0118220 A1 (published June 2, 2005) (hereinafter “Miyazaki”). 6 Shin-Etsu, Shin-Etsu Silicone — Silicone Fluid (Product Brochure) (2004) (hereinafter “Shin-Etsu”). 2 Appeal 2016-001650 Application 12/596,724 FINDINGS OF FACT We adopt the Examiner’s findings of fact, reasoning on scope and content of the prior art, and conclusions set out in the Final Action and Answer. The facts set out below highlight certain evidence. FF1. Fujiwara taught a glass flake substrate (for a cosmetic) with an average thickness of 0.1 to 1.0 pm and an average particle size of 1 to 100 pm, in that it disclosed: In the present specification, a glass flake 1 refers to thin flake-shaped particles having an average thickness t of 0.1-100 /im and an aspect ratio (average particle diameter a/average thickness t) of 2-1000 (see FIG. 2A). Herein, average particle diameter a is defined as the square root of the area S of the glass flake 1 when viewed in plan (see FIG. 2B). Fujiwara 32, 98; see also Final Action 4 (discussing Fujiwara). FF2. Fujiwara taught a coating of only methyl hydrogen polysiloxane over the glass flake particle as a hydrophobic treatment. Fujiwara 199; see also Final Action 4 (discussing Fujiwara). FF3. Miyazaki taught a cosmetic composition with a coating of methyl hydrogen polysiloxane over a 1—100 pm spherical particle where the methyl hydrogen polysiloxane was 2% by weight of the particle. Miyazaki 1138; see also Final Action 5 (discussing Miyazaki, Example 10). FF4. Shin-Etsu disclosed methylhydrogen silicone is “[sjuitable for processing glass, metal, fibers, and powders,” and is “[a] clear coating with good water repellency, mold releasability, and lubricity is obtained by baking this product onto the surface of various materials.” Shin-Etsu 5, 9; see also Final Action 6 (discussing Shin- Etsu). 3 Appeal 2016-001650 Application 12/596,724 FF5. Shin-Etsu also disclosed methylhydrogen silicone is useful in cosmetics such as “[s]kin cream,” “[mjilky lotion,” and “[fjace lotion,” because of its “[pjhysiological inertness, transparency, odorlessness, water repellency, lubricity, etc.” Shin-Etsu 9; see also Final Action 6 (discussing Shin-Etsu). DISCUSSION We find the Examiner has established a prima facie case that the claims would have been obvious over Fujiwara, Miyazaki, and Shin-Etsu. Appellants have not produced evidence showing, or persuasively argued, that the Examiner’s determination of obviousness is incorrect. Only those arguments made by Appellants in the Briefs have been considered in this Decision. Arguments not presented in the Briefs are waived. See 37 C.F.R. § 41.37(c)(l)(iv)(2015). We address Appellants’ arguments below. Appellants argue that the prior art does not suggest a coating of only methyl hydrogen silicone. App. Br. 8—10. This argument is not persuasive in view of the disclosures of Fujiwara (FF2) and Miyazaki (FF3), each of which teaches a particle coating of only methyl hydrogen polysiloxane, and the disclosure of Shin-Etsu (FF4—FF5), which teaches that the alternative material, methyl hydrogen silicone (methylhydrogen silicone), is an advantageous coating for cosmetics. Appellants also argue the criticality of the recited range of % mass methyl hydrogen silicone coating for the claimed glass flake, alleging that venturing just 0.01% lower or 0.02% higher causes significant deterioration in properties. Br. 10—11. Appellants contend this is an “unexpected improvement” provided by the invention and cite the Maeda Declaration 4 Appeal 2016-001650 Application 12/596,724 (dated Feb. 3, 2013) as evidence. Id. However, Maeda never indicates that the invention provides unexpected or surprising results, but merely identifies the results achieved with the alleged critical range to be “considerably improved” and “prominent effects.” Maeda Decl. 8. [A] prior art reference that discloses a range encompassing a somewhat narrower claimed range is sufficient to establish a prima facie case of obviousness. That is not to say that the claimed composition having a narrower range is unpatentable. Rather, the existence of overlapping or encompassing ranges shifts the burden to the applicant to show that his invention would not have been obvious. In re Peterson, 315 F.3d 1325, 1329 (Fed. Cir. 2003). The Examiner contests the significance of Appellants’ data concerning the recited range because it is not apparent how Appellants calculated their alleged 25% improvement in feeling and transparency properties and no statistical analysis of the results was provided; the Examiner suggests any differences between the invention and the prior art are not in kind, but only in degree. Ans. 10—11. The Examiner invited Appellants to explain their results in a reply brief, but none was filed. Id. To show criticality of a claimed range, “it is not inventive to discover the optimum or workable ranges by routine experimentation.” In re Aller, 220 F.2d 454, 456 (CCPA 1955). Only if the “results of optimizing a variable” are “unexpectedly good” can a patent be obtained for the claimed critical range. In re Geisler, 116 F.3d 1465, 1469 (Fed. Cir. 1997) (citing In re Antonie, 559 F.2d 618, 620 (CCPA 1977)). “Furthermore, it is well settled that unexpected results must be established by factual evidence. ‘Mere argument or conclusory statements in the specification does not suffice.’” Id. (citing In re De Blauwe, 736 F.2d 699, 705 (Fed.Cir.1994)). 5 Appeal 2016-001650 Application 12/596,724 Here, Appellants have not provided evidence that the data shown in the Specification or in Maeda Declaration establishes the results improved by the recited range were unexpected and not due to mere routine optimization. All Appellants present on this issue is attorney argument, which will not suffice to rebut the prima facie case of obviousness. SUMMARY The rejection of claims 1—7 under 35 U.S.C. § 103(a) is affirmed. TIME PERIOD FOR RESPONSE No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED 6 Copy with citationCopy as parenthetical citation